On March 8, 2021 INmune Bio, Inc. (NASDAQ: INMB) (the "Company" or "INmune"), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, reported that its management team is scheduled to participate in two upcoming virtual investor conferences in March 2021 (Press release, INmune Bio, MAR 8, 2021, View Source [SID1234576312]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

33rd Annual Roth Virtual Conference

Panel Discussion: Therapeutics Against SARS-CoV-2 – Viral Variants Will Not Fade Away
Panel Date: Monday, March 15, 2021
Panel Time: 12:00 PM Eastern Time
Interested parties may register for the panel here

Oppenheimer 31st Annual Healthcare Conference

Presentation Date: Tuesday, March 16, 2021

Presentation Time: 1:10 PM Eastern Time
Interested parties may register for the panel here

Please contact your representative at either Roth or Oppenheimer to schedule a virtual one-on-one meeting with INmune Bio during the respective conference.